| 1 |
35149540 | Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model. | 2022 May |
2 |
| 2 |
28238945 | Nose-to-brain transport of imatinib mesylate: A pharmacokinetic evaluation. | 2017 May 1 |
2 |
| 3 |
25575688 | Drug transporters play a key role in the complex process of Imatinib resistance in vitro. | 2015 Mar |
2 |
| 4 |
25916699 | Celecoxib sensitizes imatinib-resistant K562 cells to imatinib by inhibiting MRP1-5, ABCA2 and ABCG2 transporters via Wnt and Ras signaling pathways. | 2015 Jul |
1 |
| 5 |
24844604 | Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions. | 2014 Jul |
1 |
| 6 |
24210993 | Phosphorylated Crkl reduction levels are associated with the lowest P-glycoprotein activity levels in cells from chronic myeloid leukemia patients. | 2013 Dec |
7 |
| 7 |
22098951 | Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells. | 2012 Feb |
3 |
| 8 |
23230732 | [Multidrug resistant gene MDR1 contributes to development of imatinib-resistance in Ph (+) acute lymphoblastic leukemia cell line SUP-BS15RI]. | 2012 Sep |
1 |
| 9 |
21418741 | Simultaneous targeting of P-gp and XIAP with siRNAs increases sensitivity of P-gp overexpressing CML cells to imatinib. | 2011 Mar |
6 |
| 10 |
20701289 | A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib. | 2010 Oct 4 |
4 |
| 11 |
18977528 | Imatinib resistance in multidrug-resistant K562 human leukemic cells. | 2009 May |
5 |
| 12 |
19309222 | Imatinib is a substrate for various multidrug resistance proteins. | 2009 |
3 |
| 13 |
17180388 | The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate. | 2007 May |
2 |
| 14 |
17294720 | [Establishment of an imatinib resistance cell line K562R and its resistant principia]. | 2007 Jan |
1 |
| 15 |
16001089 | Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia. | 2005 Sep |
1 |
| 16 |
16320588 | [Effect of neferine on the chemotherapic sensitivity of STI 571 to K562/A02 cells]. | 2005 Oct |
1 |
| 17 |
15250677 | Use and limitations of imatinib mesylate (Glivec), a selective inhibitor of the tyrosine kinase Abl transcript in the treatment of chronic myeloid leukaemia. | 2004 |
1 |
| 18 |
15308010 | [Establishment of an imatinib resistant cell line K562/G01 and its characterization]. | 2004 Jun |
1 |